Invention Grant
- Patent Title: Beta-lactamase inhibitors
-
Application No.: US16238363Application Date: 2019-01-02
-
Publication No.: US10669290B2Publication Date: 2020-06-02
- Inventor: Christopher J. Burns , Denis Daigle , Bin Liu , Daniel McGarry , Daniel C. Pevear , Robert E. Lee Trout
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee Address: US PA Malvern
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K45/06 ; A61K31/69 ; C07F5/04 ; C07F5/02

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Public/Granted literature
- US20190225628A1 BETA-LACTAMASE INHIBITORS Public/Granted day:2019-07-25
Information query